Potential of Helper-Dependent Adenoviral Vectors in CRISPR-cas9-Mediated Lung Gene Therapy

Scientists discuss the status of the application of CRISPR/Cas9 in cystic fibrosis gene therapy, the existing challenges in the field, as well as new hurdles introduced by the presence of CRISPR/Cas9 in the lungs.